Soligenix Inc
NASDAQ:SNGX

Watchlist Manager
Soligenix Inc Logo
Soligenix Inc
NASDAQ:SNGX
Watchlist
Price: 1.27 USD Market Closed
Market Cap: 4.1m USD

Relative Value

The Relative Value of one SNGX stock under the Base Case scenario is 2.34 USD. Compared to the current market price of 1.27 USD, Soligenix Inc is Undervalued by 46%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SNGX Relative Value
Base Case
2.34 USD
Undervaluation 46%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
6
vs Industry
36
Median 3Y
89.7
Median 5Y
314.9
Industry
7.5
vs History
vs Industry
Median 3Y
-1.3
Median 5Y
-22.5
Industry
23.6
Forward
-0.4
vs History
vs Industry
Median 3Y
-1.1
Median 5Y
-24.9
Industry
20.2
vs History
vs Industry
Median 3Y
-1
Median 5Y
-23.3
Industry
22.9
vs History
88
vs Industry
62
Median 3Y
2
Median 5Y
28.7
Industry
2.8
vs History
vs Industry
86
Median 3Y
0.6
Median 5Y
252.5
Industry
7.7
vs History
vs Industry
81
Median 3Y
5.3
Median 5Y
755.8
Industry
9.6
vs History
7
vs Industry
22
Median 3Y
-0.1
Median 5Y
-20.9
Industry
4.9
vs History
7
vs Industry
20
Median 3Y
-0.1
Median 5Y
-20.8
Industry
4.9
Forward
0.3
vs History
4
vs Industry
24
Median 3Y
-0.1
Median 5Y
-23.9
Industry
5.4
vs History
4
vs Industry
20
Median 3Y
-0.1
Median 5Y
-23.9
Industry
4
vs History
0
vs Industry
13
Median 3Y
-4.2
Median 5Y
-102.5
Industry
5.1

Multiples Across Competitors

SNGX Competitors Multiples
Soligenix Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Soligenix Inc
NASDAQ:SNGX
4m USD 1 758.1 -0.4 0.3 0.3
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 932 910.7 -161 278.1 -195 843 -193 608.2
US
Abbvie Inc
NYSE:ABBV
338.3B USD 5.9 81.4 15.5 22.9
US
Amgen Inc
NASDAQ:AMGN
159.4B USD 4.7 26.9 14.4 23.8
US
Gilead Sciences Inc
NASDAQ:GILD
139.6B USD 4.9 23.4 10.2 14
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
121.6B USD 11 -122.9 26.2 27.4
US
Epizyme Inc
F:EPE
94.1B EUR 2 076.1 -529.8 -576.9 -561.5
AU
CSL Ltd
ASX:CSL
117B AUD 5.1 28 17.3 21.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
62B USD 4.4 13.8 12.4 13.9
US
Seagen Inc
F:SGT
39.3B EUR 20 -61.3 -66.1 -59.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
41.4B USD 17.6 -153.6 -688.6 -345
P/S Multiple
Revenue Growth P/S to Growth
US
Soligenix Inc
NASDAQ:SNGX
Average P/S: 3 085 165.3
1 758.1
104%
16.9
FR
Pharnext SCA
OTC:PNEXF
33 932 910.7
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.9
8%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.7
4%
1.2
US
Gilead Sciences Inc
NASDAQ:GILD
4.9
3%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
11
10%
1.1
US
E
Epizyme Inc
F:EPE
2 076.1
N/A N/A
AU
CSL Ltd
ASX:CSL
5.1
7%
0.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
4.4
4%
1.1
US
S
Seagen Inc
F:SGT
20
30%
0.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
17.6
30%
0.6
P/E Multiple
Earnings Growth PEG
US
Soligenix Inc
NASDAQ:SNGX
Average P/E: 34.7
Negative Multiple: -0.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -161 278.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
81.4
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
26.9
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
23.4
189%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -122.9 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -529.8 N/A N/A
AU
CSL Ltd
ASX:CSL
28
16%
1.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.8
7%
2
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.3 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -153.6 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Soligenix Inc
NASDAQ:SNGX
Average EV/EBITDA: 13.7
0.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 843 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.5
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.4
17%
0.8
US
Gilead Sciences Inc
NASDAQ:GILD
10.2
6%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.2
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -576.9 N/A N/A
AU
CSL Ltd
ASX:CSL
17.3
11%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.4
11%
1.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -66.1 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -688.6 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Soligenix Inc
NASDAQ:SNGX
Average EV/EBIT: 17.7
0.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -193 608.2 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.9
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
23.8
32%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
14
11%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
27.4
17%
1.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -561.5 N/A N/A
AU
CSL Ltd
ASX:CSL
21.6
14%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.9
11%
1.3
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.6 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -345 N/A N/A